MedTech Terms
    The authoritative reference
    All terms
    Market SegmentsStrategic Landscape

    Wound Care

    Devices and biologics for managing acute and chronic wounds.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Wound care includes negative-pressure wound therapy (NPWT, e.g., 3M/KCI V.A.C.), advanced dressings, cellular and tissue products (CTPs/skin substitutes), and emerging electrical stimulation and oxygen therapies.
    What the regulation says
    Wound care products are subject to classification based on their risk to patients, which dictates the regulatory pathway and pre-market submission requirements, as per FDA 21 CFR Part 860 and EU MDR Article 51. Devices such as advanced dressings typically fall into lower risk classes, while implantable or biologically derived products, like cellular and tissue products, face more stringent controls and data requirements. Manufacturers must demonstrate safety and effectiveness for their intended use, aligning with principles found in ISO 13485 for quality management systems.

    What this means in practice

    Diabetic foot ulcers and venous leg ulcers drive demand. CMS LCDs on skin substitutes have repeatedly reshaped commercial dynamics.

    Examples

    • A company developing an antimicrobial wound dressing must provide biocompatibility data and demonstrate the dressing's effectiveness against relevant pathogens.
    • A manufacturer of a new electrical stimulation device for chronic wounds needs to conduct clinical trials to prove its safety and efficacy in promoting wound closure.
    • A cellular therapy product for diabetic foot ulcers requires extensive pre-clinical testing and clinical data to support its claims of tissue regeneration and wound healing.
    Common pitfalls
    • •A common pitfall is misclassifying a novel wound care product, leading to incorrect regulatory submissions and delays. Another mistake is failing to adequately validate sterilization processes for sterile wound care devices. Manufacturers often underestimate the clinical data required for advanced wound care therapies, especially those involving biological components.
    • •Overlooking specific labeling requirements for combination products, such as drug-device wound dressings, can lead to non-compliance.
    • •Ignoring post-market surveillance data for long-term wound healing outcomes can result in missed opportunities for product improvements or safety signals.

    Frequently asked questions

    NPWT is a therapeutic technique using a vacuum dressing to promote healing in acute or chronic wounds and enhance healing of second and third degree burns. It involves applying controlled negative pressure to the wound bed through a sealed dressing, facilitating fluid removal and promoting tissue granulation.
    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Ecosystems (1)

    Mentioned in recent activity

    3 entries

    Latest in MedTech

    View all

    Recent regulatory actions, publications, and trials matched to this term. Updated daily.

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    WoundSource·1MedTech Dive·1AdvaMed·1
    1. 1
      WoundSource
      Verified
      WoundSourcewoundsource.com
    2. 2
      MedTech Dive
      Verified
      MedTech Divemedtechdive.com
    3. 3
      AdvaMed - Industry Reports
      Verified
      AdvaMedadvamed.org

    Inline markers like [1] jump to the matching reference above.